Pharmacy - Pharmacoeconomics News & Articles

1 The economic costs of pain in the united states The Journal of Pain, May 21, 2012

2 The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings Spine, May 17, 2012    Clinical Article

3 Procedure intensity and the cost of care Circulation: Cardiovascular Quality and Outcomes, May 17, 2012

4 Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF Europace, May 16, 2012

5 New data from landmark study shows cost-effectiveness of medtronic life-saving crt-d therapy in mildly symptomatic heart failure patients Full Text Medtronic, May 14, 2012

6 A Cost-Effectiveness Evaluation of Hospital Discharge Counseling by Pharmacists Journal of Pharmacy Practice, May 10, 2012

7 Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia Mycoses, May 4, 2012    Clinical Article

8 Does the united states economy affect heart failure readmissions? a single metropolitan center analysis Full Text Clinical Cardiology, April 26, 2012

9 Use and Costs of Prescription Medications and Alternative Treatments in Patients with Osteoarthritis and Chronic Low Back Pain in Community-Based Settings Pain Practice, April 23, 2012

10 Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? simulation data from the reach registry australian cohort Cardiovascular Drug Reviews, April 20, 2012    Clinical Article

11 Study shows link between greater cost-sharing and higher hospitalization rates for asthmatic children Full Text Drug Topics, April 17, 2012

12 Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database European Journal of Clinical Pharmacology, April 12, 2012

13 Quality of life and economic costs associated with postthrombotic syndrome American Journal of Health-System Pharmacy, April 10, 2012

14 Cost of targeted therapies in metastatic colorectal cancer Journal de Pharmacie Clinique, April 10, 2012

15 Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease-A cost-effectiveness analysis BMC Cardiovascular Disorders, April 5, 2012    Clinical Article

16 Benefit design continues to be influenced by rising medical, pharmacy costs Full Text Formulary , April 4, 2012

17 Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program PharmacoEconomics, March 30, 2012

18 Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues PharmacoEconomics, March 29, 2012

19 Cost effectiveness of anticoagulation in acute coronary syndromes PharmacoEconomics, March 29, 2012

20 Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up Therapeutic Advances in Respiratory Disease, March 27, 2012    Clinical Article

1 Benefit design continues to be influenced by rising medical, pharmacy costs Formulary , April 4, 2012    Free full text

2 Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease-A cost-effectiveness analysis BMC Cardiovascular Disorders, April 5, 2012

3 A methodological framework for estimating the clinical and economic value of community pharmacists' clinical interventions using expert opinion Journal of Clinical Pharmacy and Therapeutics, March 23, 2012

4 Rise in human and healthcare costs of dementia PhRMA, March 9, 2012    Free full text

5 Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? simulation data from the reach registry australian cohort Cardiovascular Drug Reviews, April 20, 2012

6 Study shows link between greater cost-sharing and higher hospitalization rates for asthmatic children Drug Topics, April 17, 2012    Free full text

7 Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma Clinical Drug Investigation, March 13, 2012

8 A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri Lanka BMC Clinical Pharmacology, February 23, 2012    Free full text

9 Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database European Journal of Clinical Pharmacology, April 12, 2012

10 Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings Pain Practice, March 15, 2012

11 Cost effectiveness of anticoagulation in acute coronary syndromes PharmacoEconomics, March 29, 2012

12 Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program PharmacoEconomics, March 30, 2012

13 Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues PharmacoEconomics, March 29, 2012

14 New Acquisition of Antibiotic Resistant Organisms in Skilled Nursing Facilities Journal of Clinical Microbiology, March 1, 2012

15 Use and Costs of Prescription Medications and Alternative Treatments in Patients with Osteoarthritis and Chronic Low Back Pain in Community-Based Settings Pain Practice, April 23, 2012

16 Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up Therapeutic Advances in Respiratory Disease, March 27, 2012

17 Healthcare costs associated with osteoarthritis in US patients Pain Practice, March 12, 2012

18 Three-year financial analysis of pharmacy services at an independent community pharmacy Journal of the American Pharmacists Association, March 19, 2012